Oday Hamid

Oday Hamid, PharmD, is a seasoned professional in oncology and clinical development with over 23 years of experience in the pharmaceutical industry. Currently serving as Senior Director in Clinical Development for Early Phase Oncology at AstraZeneca since January 2018, Oday also holds the position of Adjunct Professor at the University of Michigan, where responsibilities include mentoring pharmacy students in drug development and clinical trial management. Prior experience includes over a decade at Eli Lilly and Company as a Principal Clinical Scientist, focusing on oncology/hematology clinical trials and regulatory document preparation, as well as a role at Pfizer as a Clinical Scientist. Oday's academic credentials include a Doctor of Pharmacy (Pharm.D.) from the University of Illinois Chicago and a Bachelor's degree in Pharmacy from Wayne State University.